Clinical Trial Update: A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients

View source ↗

Summary

A real-world study evaluating how adverse events influence treatment changes, healthcare resource use, and costs in chronic myeloid leukemia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Leukemia, Chronic Myeloid | Status: COMPLETED